TeraRecon specializes in advanced visualization and artificial intelligence (AI) solutions tailored for medical imaging across various specialties, including radiology, cardiology, and neurology. Their platform is designed to enhance patient care by automating insights and improving clinical workflows. By integrating AI-driven decision support, TeraRecon enables healthcare professionals to pair their clinical intuition with advanced technology, leading to faster diagnosis and treatment. The platform also emphasizes flexibility, allowing users to interact with AI results and make informed adjustments to imaging findings, thereby streamlining the patient care process.

One of the standout features of TeraRecon's technology is its Bone Suppression capability, which enhances the diagnostic value of existing chest radiographs without additional risk to patients. This innovative approach not only aids in achieving more accurate diagnoses but also contributes to significant time savings for healthcare providers. By consolidating multiple 3D and AI solutions into a single subscription-based platform, TeraRecon aims to minimize costs while maximizing the efficiency and effectiveness of medical imaging workflows, ultimately improving patient outcomes.

Germany

Serving ~1,900 clinical sites globally, TeraRecon, a ConcertAI company, is a Best in KLAS solution provider for AI-empowered radiology, oncology, cardiology, neurology, and vascular surgery. Awarded the KLAS Category Leader for Advanced Visualization, TeraRecon solutions are independent of any one manufacturer's imaging equipment or PACS system, allowing a single, unified, and simplified clinical workflow that can improve efficiencies and deliver actionable physician-guided insights. 

TeraRecon

Company Details